Endonuclease Barcoding for High-Throughput Cell Tracking

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current DNA editing tools, such as CRISPR/Cas9, face challenges including flexibility issues, off-target DNA cleavage, variable efficiency, and incompatibility with cell growth modifications, requiring time-consuming clone selection and limiting high-throughput applications in eukaryotic cells.

Innovation Solution

A method involving endonuclease-based 'barcoding' where silent mutations are introduced to label cells, allowing for the detection of genetic modifications by comparing distinct signatures within cell populations, reducing the need for clone selection and enhancing high-throughput capabilities.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If endonuclease-based genome editing is used to introduce precise genetic modifications, then manufacturing precision is improved, but loss of time increases due to required clone selection

Engineering Contradiction:
Improvegenetic modification precisionVSAvoidclone selection time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The patent applies preliminary action by introducing barcoding sequences and silent mutations during the initial genome editing step. These barcodes are incorporated into the donor DNA template before the editing process, so that when HDR occurs, the barcode is simultaneously introduced. This preliminary preparation eliminates the need for subsequent clone selection and sequencing to identify edited cells, as the barcode provides immediate identification.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses copying by creating unique barcode sequences that are copied into the genome along with the desired genetic modification. These barcodes serve as molecular copies or tags that can be detected and used to identify and track specific edited cells without requiring further manipulation or selection steps.

Inventive Principle:
Principle #26Copying

2Adaptability or versatility

If conventional DNA editing tools are used, then adaptability is improved, but object-generated harmful factors worsen due to off-target DNA cleavage

Engineering Contradiction:
Improvegenome editing flexibilityVSAvoidoff-target DNA cleavage
Core Design Contradiction:
Adaptability or versatilityVSObject-generated harmful factors

Solution Approach 1:

The patent implements feedback by using the introduced barcodes to monitor and identify cells that have successfully undergone the desired editing. The barcode system provides a readout mechanism that confirms on-target editing occurred, allowing researchers to select only those cells with the intended modifications. This feedback loop enables verification of editing specificity without requiring extensive off-target analysis.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The barcode sequences serve as intermediaries between the genome editing process and the detection/selection system. Rather than directly detecting the genetic modification itself, the system uses the barcode as a mediator that can be easily read and used to identify edited cells. This intermediary approach simplifies verification and reduces the need for complex off-target screening.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Ease of operation

If CRISPR/Cas9 system is used for genome editing, then ease of operation is improved, but reliability worsens due to variable editing efficiency

Engineering Contradiction:
Improvegenome editing ease-of-useVSAvoidDNA editing efficiency
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The barcode system provides feedback that allows researchers to determine the actual editing efficiency of their CRISPR/Cas9 experiment. By sequencing or detecting the barcodes in the cell population, researchers can quantify what fraction of cells successfully underwent HDR with the donor template. This feedback enables optimization of editing conditions and accurate assessment of experimental outcomes.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system applies self-service by allowing the edited cells to carry their own identification tags (barcodes) that enable automatic identification and tracking. The barcodes are self-incorporated during the HDR process, eliminating the need for separate labeling steps or complex selection procedures, thereby maintaining ease of operation while improving reliability through accurate efficiency measurement.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables fast, convenient, and effective characterization of genetic modifications in eukaryotic cells, reducing off-target effects and improving the efficiency of DNA editing by allowing for the tracking of modified cells within heterogeneous populations.

Implementation Method 1

The mechanism behind endonuclease-based genome editing generally requires a first step of DNA single or double strand break

Methodology Applied
Scientific EffectEndonuclease cleavage: Enzyme

Implementation Method 2

In HDR, a donor nucleic acid co-introduced into the cells functions as a template for precise repair

Methodology Applied
Scientific EffectHomology-directed repair (HDR):

Implementation Method 3

the error-prone nonhomologous end-joining (NHEJ)

Methodology Applied
Scientific EffectNon-homologous end-joining (NHEJ):

Data Source

PatentUS20220307012A1Endonuclease-barcoding
Publication Date: 2022.09.29 INST NAT DE LA SANTE & DE LA RECHERCHE MEDICALE (INSERM)
  • US20220307012A1 patent drawing
  • US20220307012A1 patent drawing
  • US20220307012A1 patent drawing

AI summary

The instant invention relates to a method for labeling endonuclease-treated cells, comprising the steps of a) providing cells or a composition comprising cells; b) bringing into contact said cells or said composition with: —at least one endonuclease suitable for targeting a genomic region of interest in said cells, or a vector suitable for expressing said endonuclease in said cells; —at least one first nucleic acid suitable for introducing one or more silent mutation(s) in said genomic region by homology-directed repair (HDR), and optionally one or more non-silent mutation(s); and —at least one second nucleic acid suitable for introducing one or more silent mutation(s) in said genomic region by homology-directed repair (HDR), but distinct from the silent mutations of the first nucleic acid; thereby labeling endonuclease-treated cells.